Psykey, Inc. (CEOS)
USD 0.01
(-24.66%)
USD 0.01
(-24.66%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 634.59 Thousand USD | -51.87% |
| 2022 | 1.31 Million USD | 200.63% |
| 2021 | 438.59 Thousand USD | 0.0% |
| 2020 | - USD | -100.0% |
| 2019 | 3933.20 USD | 0.0% |
| 2018 | 3933.20 USD | 0.0% |
| 2016 | 3.9 Million USD | 10.21% |
| 2015 | 3.54 Million USD | 78.68% |
| 2014 | 1.98 Million USD | 0.0% |
| 2007 | -574.58 Thousand USD | 89.66% |
| 2006 | -5.55 Million USD | -597756.88% |
| 2005 | 930.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 FY | 634.59 Thousand USD | -51.87% |
| 2023 Q3 | 1.52 Million USD | 7.21% |
| 2023 Q4 | 634.59 Thousand USD | -58.33% |
| 2023 Q1 | 1.38 Million USD | 5.08% |
| 2023 Q2 | 1.42 Million USD | 2.54% |
| 2022 Q2 | 559.83 Thousand USD | 10.36% |
| 2022 Q4 | 1.31 Million USD | 8.09% |
| 2022 FY | 1.31 Million USD | 200.63% |
| 2022 Q1 | 507.26 Thousand USD | 15.66% |
| 2022 Q3 | 1.21 Million USD | 117.9% |
| 2021 Q1 | 32.27 Thousand USD | 0.0% |
| 2021 FY | 438.59 Thousand USD | 0.0% |
| 2021 Q4 | 438.59 Thousand USD | 853.37% |
| 2021 Q3 | -58.21 Thousand USD | -1025.42% |
| 2021 Q2 | -5173.00 USD | -116.03% |
| 2020 FY | - USD | -100.0% |
| 2019 FY | 3933.20 USD | 0.0% |
| 2018 FY | 3933.20 USD | 0.0% |
| 2016 FY | 3.9 Million USD | 10.21% |
| 2015 FY | 3.54 Million USD | 78.68% |
| 2014 FY | 1.98 Million USD | 0.0% |
| 2008 Q2 | -586.2 Thousand USD | -777.78% |
| 2008 Q3 | 73.55 Thousand USD | 112.55% |
| 2008 Q1 | -66.78 Thousand USD | 88.38% |
| 2007 FY | -574.58 Thousand USD | 89.66% |
| 2007 Q4 | -574.58 Thousand USD | 66.05% |
| 2007 Q1 | -3.58 Million USD | 35.54% |
| 2007 Q3 | -1.69 Million USD | 30.85% |
| 2007 Q2 | -2.44 Million USD | 31.69% |
| 2006 Q4 | -5.55 Million USD | -43.78% |
| 2006 Q2 | -2.37 Million USD | 46.01% |
| 2006 FY | -5.55 Million USD | -597756.88% |
| 2006 Q1 | -4.4 Million USD | 0.0% |
| 2006 Q3 | -3.86 Million USD | -62.71% |
| 2005 FY | 930.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -32.309% |
| Ansell Limited | -54.99 Million USD | 101.154% |
| Ansell Limited | -55.1 Million USD | 101.152% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 101.739% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 703.788% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.947% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.947% |
| Encision Inc. | 1.29 Million USD | 50.833% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 72.513% |
| Innovative MedTech Inc. | 1.76 Million USD | 64.04% |
| LifePoint, Inc. | -3.26 Million USD | 119.442% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 87.06% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 70.648% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 1565.437% |
| Reflect Scientific, Inc. | -1.03 Million USD | 161.295% |
| SmileDirectClub, Inc. | 778.67 Million USD | 99.919% |
| Sector 10, Inc. | 163 Thousand USD | -289.321% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 100.152% |
| SheerVision, Inc. | 57.34 Thousand USD | -1006.546% |
| United Health Products, Inc. | 660.56 Thousand USD | 3.932% |
| Vasamed, Inc. | 22.12 Thousand USD | -2768.606% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 75.882% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 17.829% |